Identify opportunities, optimize leads and reveal potential
off-target liabilities with results that are timely, accurate
and reproducible.

KINOMEscan™ provides outstanding data with an integrated
suite of screening and profiling solutions to inform decision
making throughout the kinase drug development continuum.

New Customer Pilot Pricing - Buy three, get one free!
From now until July 31st 2011, receive one free compound
screen against scanMAX - our largest and most popular kinase panel with the purchase of three. Some exclusions apply,
please see website for details. Request a quote»

Learn more about KINOMEscan™ Kinase Inhibitor Profiling Services:
• Online tutorial
• User testimonials & case studies
• Publications
• Performance data

Binding Affinities of Type I, II & Allosteric Inhibitors

Screening & Profiling Solutions
• Single Target HTS -
  Compound Library Profiling
• Custom Assay Panels
• Lead Optimization & SAR
• Preclinical & Compound
  Safety
• Mechanism of Action Studies
• Assay Development Services

The KINOMEscan™ Advantage
• Accurate, Precise &
  Reproducible Data
• Data Turnaround in Under
  Two Weeks
• Dynamic Range:
  < 100 pM - > 10 µM
• Non-type I Inhibitor
  Detection
• Largest Commercial Assay
  Panel
• Binding Mode Elucidation

Learn more at
www.kinomescan.com/standout